FLAVIN JOHN L 4
4 · Pyxis Oncology, Inc. · Filed Apr 2, 2025
Insider Transaction Report
Form 4
FLAVIN JOHN L
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-03-31$0.98/sh+36,979$36,239→ 36,979 totalExercise: $0.98Exp: 2035-03-31→ Common Stock (36,979 underlying)
Footnotes (1)
- [F1]The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.